RGEN vs BIO-B

Comparison between Repligen Corp (RGEN, Company) and Bio-Rad Laboratories Inc - Class B (BIO-B, Company).

Both RGEN and BIO-B are from the Healthcare sector.

5-Year PerformanceRGEN has outperformed BIO-B, delivering a return of -5.6% compared to -14.5%

RGEN vs BIO-B - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RGEN(COMPANY)	BIO-B(COMPANY)
Market Cap	$8.35B	$8.34B
Max Drawdown	92.06%	72.48%
Sharpe Ratio	0.58	0.59
5Y Beta	1.33	-0.10
Industry	Medical Instruments & Supplies	Medical Devices
P/E Ratio	162.20	-16.92
Forward P/E	73.53	34.97
PEG Ratio	0.62	N/A
5Y EPS CAGR	9.09%	N/A
Debt to Equity	25.96%	11.72%
Free Cash Flow Yield	1.27%	4.28%

Market Cap

Winner

RGEN

$8.35B

BIO-B

$8.34B

Max Drawdown

RGEN

92.06%

Winner

BIO-B

72.48%

Sharpe Ratio

RGEN

0.58

Winner

BIO-B

0.59

5Y Beta

RGEN

1.33

Winner

BIO-B

-0.10

Industry

RGEN

Medical Instruments & Supplies

BIO-B

Medical Devices

P/E Ratio

RGEN

162.20

Winner

BIO-B

-16.92

Forward P/E

RGEN

73.53

Winner

BIO-B

34.97

PEG Ratio

RGEN

0.62

BIO-B

N/A

5Y EPS CAGR

RGEN

9.09%

BIO-B

N/A

Debt to Equity

RGEN

25.96%

Winner

BIO-B

11.72%

Free Cash Flow Yield

RGEN

1.27%

Winner

BIO-B

4.28%

RGEN vs BIO-B - Historical Returns

Returns include dividend reinvestment.

Period	RGEN	BIO-B
1 month	+13.14%	+1.72%
3 months	+12.23%	+11.69%
6 months	-8.43%	-0.43%
1 year	+25.37%	+20.03%
5 years(CAGR)	-5.56%	-14.46%
10 years(CAGR)	+18.53%	+8.10%
Max(CAGR)	+15.46%	+13.08%

Winner

RGEN

+13.14%

BIO-B

+1.72%

Winner

RGEN

+12.23%

BIO-B

+11.69%

RGEN

-8.43%

Winner

BIO-B

-0.43%

Winner

RGEN

+25.37%

BIO-B

+20.03%

5Y(CAGR)

Winner

RGEN

-5.56%

BIO-B

-14.46%

10Y(CAGR)

Winner

RGEN

+18.53%

BIO-B

+8.10%

Max(CAGR)

Winner

RGEN

+15.46%

BIO-B

+13.08%

RGEN vs BIO-B - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	RGEN	BIO-B
2026	-9.91%	-0.43%
2025	+14.55%	-4.58%
2024	-19.72%	+1.54%
2023	+10.99%	-20.76%
2022	-34.37%	-44.94%
2021	+38.91%	+25.91%
2020	+104.34%	+54.89%
2019	+78.95%	+60.70%
2018	+42.31%	-3.46%
2017	+16.47%	+30.08%
2016	+9.68%	+33.03%
2015	+40.75%	+14.67%
2014	+56.77%	-2.37%
2013	+105.73%	+15.80%
2012	+79.43%	+6.31%
2011	-23.23%	-9.98%
2010	+16.09%	+6.86%
2009	+4.85%	+31.80%
2008	-43.16%	-30.83%
2007	+133.93%	+28.86%
2006	-27.95%	+28.31%
2005	+37.93%	+14.04%
2004	-30.77%	-2.64%
2003	+47.14%	+36.47%
2002	+13.01%	+32.81%
2001	-31.63%	+103.17%
2000	+10.19%	+36.25%
1999	-1.98%	-0.56%

RGEN vs BIO-B Drawdown Comparison

The maximum drawdown for RGEN was -92.06%, occurring on Jul 23, 2004. Recovery took 3565 trading sessions.

The maximum drawdown for BIO-B was -72.48%, occurring on Apr 9, 2025. This drawdown has not yet recovered.

The current RGEN drawdown is -54.33%. The current BIO-B drawdown is -62.21%.

Rank	RGEN	BIO-B
#1	-92.06% Mar 3, 2000 - May 7, 2014	-72.48% Sep 10, 2021 - Apr 9, 2025
#2	-68.27% Sep 23, 2021 - May 15, 2026	-50.14% Aug 11, 2008 - Apr 20, 2010
#3	-50.33% Jul 7, 2015 - Jun 23, 2017	-35.34% Mar 1, 2000 - Nov 29, 2000
#4	-39.47% Nov 18, 1999 - Jan 24, 2000	-34.33% Jun 19, 2002 - May 20, 2003
#5	-32.87% Sep 18, 2017 - Jun 22, 2018	-31.86% Sep 4, 2018 - Aug 2, 2019
#6	-29.94% Nov 8, 2018 - Apr 26, 2019	-31.00% May 3, 2011 - Jan 9, 2014
#7	-26.69% Feb 12, 2021 - Jul 27, 2021	-27.68% Nov 8, 2007 - Aug 11, 2008
#8	-26.06% Feb 18, 2000 - Mar 1, 2000	-25.78% May 3, 2010 - Mar 7, 2011
#9	-24.16% Jul 14, 2014 - Oct 28, 2014	-23.33% Dec 26, 2003 - Aug 2, 2005
#10	-23.73% Oct 30, 2014 - Jan 16, 2015	-22.65% Feb 1, 2007 - Sep 27, 2007
#11	-22.69% Aug 1, 2019 - Jan 9, 2020	-20.71% May 17, 2002 - Jun 17, 2002
#12	-22.16% Feb 19, 2020 - Apr 22, 2020	-19.75% Feb 18, 2020 - Apr 14, 2020
#13	-19.46% May 15, 2020 - Jul 30, 2020	-19.59% Jun 6, 2003 - Dec 26, 2003
#14	-17.65% Feb 10, 2000 - Feb 15, 2000	-18.74% Feb 20, 2014 - Mar 12, 2015
#15	-15.69% Jan 19, 2021 - Feb 11, 2021	-18.70% Nov 6, 2020 - Feb 12, 2021